Fundz

Octozi raises $3M in seed funding, led by Surface Ventures, to enhance clinical development with Agentic AI solutions.

PRIVATEJul 07, 2026

Amount Raised

$3 Million

Round Type

Seed

New YorkBiotechnologySoftwareHealth CareArtificial Intelligence

Investors

Remarkable VenturesSurface Ventures

Description

Octozi, an AI company that automates clinical development workflows, has secured $3 million in seed funding. The funding round was led by Surface Ventures, with additional participation from Remarkable Ventures. Octozi's platform aims to streamline data processes in clinical trials and improve efficiency. The funding will help advance their AI-driven solutions in the pharmaceutical sector.

Who else raised in Biotechnology and Software around the same time

Companies in the same sectors as Octozi that raised within 45 days of this round, from Fundz verified event records.

  • Odysight.ai raised $11M (Post-IPO Equity) on August 21, 2026.
  • Telepatía AI raised $33M (Series A) on July 9, 2026.
  • Nerveli raised $170K (Pre-Seed) on June 29, 2026.
  • Perceptic raised $12M (Seed) on May 27, 2026.
  • Eyedentity raised $1.5M (Seed) on August 21, 2026.
  • Biorce raised $51M (Series A) on August 20, 2026.

Who to call at Octozi, and when

A new round usually means Octozi is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Octozi raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Octozi, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Octozi. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Octozi

Location

New York, New York, United States

About

Octozi is a New York-based artificial intelligence company that automates clinical trial data operations for pharmaceutical sponsors and contract research organizations. Its human-in-the-loop platform integrates with existing clinical systems to automate the cleaning, reconciliation, review, and reporting of trial data.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Octozi raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsErik D., Chief Medical Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Octozi's next move

See what Strategic adds

Octozi raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.